Great Point Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 41 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 34 |
|
|
2019
Q1 | – | Sell |
-40,197
| Closed | -$2.93M | – | 32 |
|
|
2018
Q4 | $2.93M | Sell |
40,197
-259,803
| -87% | -$18.9M | 0.37% | 31 |
|
|
2018
Q3 | $26.3M | Buy |
300,000
+39,900
| +15% | +$3.49M | 4.09% | 11 |
|
|
2018
Q2 | $25.6M | Buy |
+260,100
| New | +$25.6M | 3.55% | 11 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 38 |
|
|
2017
Q3 | – | Sell |
-276,800
| Closed | -$22.1M | – | 32 |
|
|
2017
Q2 | $22.1M | Buy |
276,800
+265,283
| +2,303% | +$21.2M | 3.96% | 11 |
|
|
2017
Q1 | $590K | Sell |
11,517
-40,418
| -78% | -$2.07M | 0.12% | 31 |
|
|
2016
Q4 | $1.94M | Buy |
+51,935
| New | +$1.94M | 0.4% | 29 |
|